SCHEMBL6954221

SCHEMBL6954221

NCCON=C(CCn1ccnc1)c1cccc(C(F)(F)F)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXA2R P21731 12/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
HIF1A Q16665 2/20 0.43
MEN1 O00255 1/20 0.43
LMNA P02545 1/20 0.43
KMT2A Q03164 1/20 0.43
NFKB1 P19838 1/20 0.43
SLC6A2 P23975 1/20 0.43
SLC6A4 P31645 1/20 0.43
ADRA1A P35348 1/20 0.43
OPRK1 P41145 1/20 0.43
SLC6A3 Q01959 1/20 0.43
KCNH2 Q12809 1/20 0.43
SCN5A Q14524 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
SIGMAR1 Q99720 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6949053 0.99 TBXA2R (0.42) TBXA2RCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6948590 0.88 CYP1A2 (0.56) TBXA2RCYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL6949500 0.87 CYP1A2 (0.55) TBXA2RCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6950410 0.84 TBXA2R (0.58) TBXA2RTBXAS1
SCHEMBL6952666 0.82 SLC6A4 (0.60) TBXA2RCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6947674 0.81 SLC6A4 (0.62) TBXA2RCYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL6950740 0.81 SLC6A4 (0.59) TBXA2RCYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL6953057 0.80 SLC6A4 (0.61) TBXA2RCYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL6946854 0.80 SLC6A4 (0.54) TBXA2RCYP1A2CYP3A4CYP2D6CYP2C9
Hydrochloric Acid SCHEMBL8666242 0.79 SLC6A4 (0.53) TBXA2RCYP1A2CYP3A4CYP2D6CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0709378-B1 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds AVENTIS PHARMA INC (US) 2003-03-19 EP claimed
US-5696142-A TREATING DEPRESSION, OBSESSIVE COMPULSIVE DISORDERS HOECHST MARION ROUSSEL, INC. (US) 1997-12-09 US claimed
EP-0709378-A2 Aminoalkyloximes, a process for their preparation, their use as medicaments and intermediate compounds HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1996-05-01 EP claimed